obesity

Novo Nordisk axes experimental obesity drugs after success with later-stage meds
Novo Nordisk axes experimental obesity drugs after success with later-stage meds
Fierce Biotech
Novo Nordisk
obesity
semaglutide
Flag link:
Heart Drugs May Influence Gut Microbiome In Obese People, Says New Study
Heart Drugs May Influence Gut Microbiome In Obese People, Says New Study
Forbes
microbiome
obesity
statins
Flag link:
Will Novo’s big thinking in obesity pay off?
Will Novo’s big thinking in obesity pay off?
EP Vantage
Novo Nordisk
obesity
Ozempic
AM833
clinical trials
Flag link:
Insights into how Novo Nordisk's Saxenda cuts food cravings may inspire new obesity drugs
Insights into how Novo Nordisk's Saxenda cuts food cravings may inspire new obesity drugs
Fierce Biotech
Novo Nordisk
Saxenda
obesity
food cravings
Flag link:
Kintai’s obesity drug that works via the gut microbiome moves closer to the clinic
Kintai’s obesity drug that works via the gut microbiome moves closer to the clinic
Fierce Biotech
microbiome
obesity
Kintai Therapeutics
Flag link:
Gene therapy to fend off aging? Buzzy Harvard startup Rejuvenate Bio says it works in mice
Gene therapy to fend off aging? Buzzy Harvard startup Rejuvenate Bio says it works in mice
Fierce Biotech
gene therapy
age-related disease
type 2 diabetes
obesity
heart failure
kidney failure
Rejuvenate Bio
Flag link:
Highlights: 2019 Cardiometabolic Health Congress, Chicago IL
Highlights: 2019 Cardiometabolic Health Congress, Chicago IL
CP Wire
cardiometabolic health
GLP-1 agonist
diabetes
lipids
hypertension
chronic kidney disease
heart failure
obesity
Flag link:
Highlights: 2019 Cardiometabolic Health Congress, Chicago IL
cardiometabolic health
GLP-1 agonist
diabetes
lipids
hypertension
chronic kidney disease
heart failure
obesity
Flag link:
Novo Nordisk announces obesity digital health tie-up with Noom
Novo Nordisk announces obesity digital health tie-up with Noom
Pharmaforum
Novo Nordisk
Noom
digital health
obesity
Flag link:
J&J dumps Hanmi obesity drug following midphase trials
J&J dumps Hanmi obesity drug following midphase trials
Fierce Biotech
JNJ
HM12525A
obesity
Hanmi Pharmaceutical
Flag link:
Boehringer Ingelheim, Gubra to develop anti-obesity peptide poly-agonists
Boehringer Ingelheim, Gubra to develop anti-obesity peptide poly-agonists
Pharmaceutical Business Review
obesity
peptide poly-agonists
Boehringer Ingelheim
Gubra
Flag link:
Even as obesity rates climb, new diabetes cases fall
Even as obesity rates climb, new diabetes cases fall
Stat
diabetes
obesity
Flag link:
FDA approves PureTech’s obesity device Plenity
FDA approves PureTech’s obesity device Plenity
Pharmaforum
FDA
PureTech Health
devices
obesity
Plenity
Flag link:
Obalon to lay off half its workforce in retail pivot
Obalon to lay off half its workforce in retail pivot
Mass Device
Obalon
layoffs
devices
obesity
Flag link:
Merck doubles down on NGM Bio pact but culls obesity drug
Merck doubles down on NGM Bio pact but culls obesity drug
Fierce Biotech
Merck
R&D
NGM Biopharmaceuticals
NP201
NASH
obesity
Flag link:
With Obesity on the Continued Rise in the U.S., More Anti-Obesity Drugs Are Heading for the Market
With Obesity on the Continued Rise in the U.S., More Anti-Obesity Drugs Are Heading for the Market
BioSpace
obesity
Sanofi
Novo Nordisk
AstraZeneca
Flag link:
Obalon Scores Funding on the Heels of Obesity Market Shift
Obalon Scores Funding on the Heels of Obesity Market Shift
Medical Devices and Diagnostics Industry
Obalon
obesity
devices
Flag link:
LNC Therapeutics Acquires Exclusive License for Microbes Potentially Related to Obesity
LNC Therapeutics Acquires Exclusive License for Microbes Potentially Related to Obesity
CP Wire
LNC Therapeutics
microbiome
obesity
Flag link:
Belviq Study Results May Improve The Fortunes Of Weight-Loss Drugs
Belviq Study Results May Improve The Fortunes Of Weight-Loss Drugs
Forbes
obesity
Belviq
Flag link:
Novo Nordisk adds to diabetes pipeline with Evotec deal
Novo Nordisk adds to diabetes pipeline with Evotec deal
Fierce Biotech
Novo Nordisk
Evotec
drug development
small molecule drugs
obesity
diabetes
Flag link:

Pages